topstockalerts
CSL announced Tuesday that it has partnered with Amazon Web Services to integrate artificial intelligence and cloud computing across its research and clinical development operations, as the healthcare company seeks to accelerate data-driven drug development.
The collaboration is designed to help CSL scientists connect and analyze large volumes of scientific data, identify potential therapeutic targets at earlier stages and evaluate external research and business opportunities more quickly. The companies also aim to create closer links between laboratory experiments and computational research, allowing experimental results to be incorporated into research models and decision-making with less delay.
In clinical development, CSL plans to use AWS technology to reduce manual work in areas including protocol drafting, clinical data management and regulatory documentation.
$CSL $AMZN
